- ORCID iD
-
0000-0003-3939-9576
Show
Sort by
-
- Miscellaneous
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study (vol 72, pg 475, 2022)
-
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial
-
- Journal Article
- A1
- open access
Minimal information for studies of extracellular vesicles (MISEV2023) : from basic to advanced approaches
-
- Journal Article
- A1
- open access
Identification and validation of extracellular vesicle reference genes for the normalization of RT‐qPCR data
-
Extracellular vesicle analysis
-
- Journal Article
- A1
- open access
Integrating automated liquid handling in the separation workflow of extracellular vesicles enhances specificity and reproducibility
-
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
-
Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles
(2022) -
- Journal Article
- A1
- open access
Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer
-
- Conference Paper
- C3
- open access
Automated liquid handling for highly specific and reproducible density‐based separation of extracellular vesicles from human body fluids